Rankings
▼
Calendar
BOLD Q2 2023 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena
BOLD
Boundless Bio, Inc.
$26M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$14M
Net Income
-$12M
EPS (Diluted)
$-0.56
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$927,000
Balance Sheet
Total Assets
$155M
Total Liabilities
$259M
Stockholders' Equity
-$104M
Cash & Equivalents
$41M
← FY 2023
All Quarters
Q3 2023 →